Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban.



Chao, Tze-Fan, Chan, Yi-Hsin, Tsai, Pei-Chien, Lee, Hsin-Fu, Chang, Shang-Hung, Kuo, Chi-Tai, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Chen, Shih-Ann and Yeh, Yung-Hsin ORCID: 0000-0003-1645-1941
(2022) Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban. Biomedicines, 10 (12). 3210-.

Access the full-text of this item by clicking on the Open Access link.

Abstract

Background: Although direct oral anticoagulants (DOACs) for patients with atrial fibrillation (AF) are considered to be safe, over or under anticoagulation and increased bleeding or thromboembolic risk are still considered individually. We aimed to investigate whether there is an association between prothrombin time and international normalized ratio (PT-INR) or activated partial thromboplastin time (aPTT) ratio, and the risks of ischemic stroke/systemic embolism (IS/SE) and major bleeding among AF patients taking rivaroxaban or dabigatran. Methods: This multi-center cohort study in Taiwan included 3192 AF patients taking rivaroxaban and 958 patients taking dabigatran for stroke prevention where data about PT-INR and aPTT were available. Results: For patients treated with rivaroxaban, a higher INR level was not associated with a higher risk of major bleeding compared to an INR level < 1.1. The risk of IS/SE was lower for patients having an INR ≥ 1.5 compared to those with an INR < 1.1 (aHR:0.57; [95%CI: 0.37−0.87]; p = 0.01). On-label dosing of rivaroxaban and use of digoxin were independent factors associated with an INR ≥ 1.5 after taking rivaroxaban. For patients taking dabigatran, a higher aPTT ratio was not associated with a higher risk of major bleeding. The risk of IS/SE was lower for patients having an aPTT ratio of 1.1−1.2 and 1.3−1.4 than those with an aPTT ratio < 1.1. Conclusions: In AF patients, rivaroxaban with an INR ≥ 1.5 was associated with a lower risk of IS/SE. PT-INR or aPTT ratios were not associated with bleeding events for rivaroxaban or dabigatran. INR may help predict the outcome of AF patients who take rivaroxaban.

Item Type: Article
Uncontrolled Keywords: DOACs, activated partial thromboplastin time, atrial fibrillation, ischemic stroke, major bleeding, prothrombin time
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 30 Jan 2023 09:27
Last Modified: 17 Mar 2023 09:35
DOI: 10.3390/biomedicines10123210
Open Access URL: https://doi.org/10.3390/biomedicines10123210
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3167949